Onset of connective tissue disease following anti-PD1/PD-L1 cancer immunotherapy

Autor: Pascale Chrétien, Xavier Mariette, Jean-Marie Michot, Sébastien Le Burel, Laurence Albiges, Anne-Laure Voisin, Stéphane Champiat, Emilie Routier, Sandrine Aspeslagh, Olivier Lambotte, Tali-Anne Szwebel
Přispěvatelé: Medical Oncology, Laboratory for Medical and Molecular Oncology
Rok vydání: 2017
Předmět:
Antineoplastic Agents
Immunological/adverse effects

Male
medicine.medical_specialty
Immunology
Autoimmunity
General Biochemistry
Genetics and Molecular Biology

Connective Tissue Diseases/chemically induced
Autoimmune Diseases
03 medical and health sciences
Antineoplastic Agents
Immunological

0302 clinical medicine
Rheumatology
Neoplasms
medicine
Humans
Immunology and Allergy
Sjøgren's Syndrome
Prospective Studies
Registries
Connective Tissue Diseases
Adverse effect
Prospective cohort study
Cryoglobulinemic vasculitis
Myositis
Aged
Autoantibodies
030203 arthritis & rheumatology
Biochemistry
Genetics and Molecular Biology(all)

business.industry
Autoantibody
Cancer
Middle Aged
medicine.disease
Connective tissue disease
Dermatology
Neoplasms/drug therapy
Treatment
030220 oncology & carcinogenesis
Female
Autoantibodies/blood
business
Complication
Zdroj: Annals of the Rheumatic Diseases. 77:468-470
ISSN: 1468-2060
0003-4967
DOI: 10.1136/annrheumdis-2016-210820
Popis: Although treatment with immune checkpoint inhibitors (ICIs) is associated with better survival in many cancer settings, these therapeutics can induce immune-related adverse events (IrAEs).1 ,2 REISAMICi is a French, prospective, multicentre, academic registry sponsored by the Gustave Roussy Institute cancer centre. The objective is to better detect, document and manage IrAEs. Connective tissue diseases (CTD) have not previously been reported in patients treated with anti-PD1/PDL-1 agents. The REISAMIC registry was screened for reports of CTD. Of the 447 patients supervised in the REISAMIC registry, three have developed CTD: two cases of Sjogren's syndrome and one case of cryoglobulinemic vasculitis as a complication of suspected Sjogren's syndrome (table 1). A case of ANA+ myositis registered in REISAMIC by another investigating centre …
Databáze: OpenAIRE